Search results for "Lymph"

showing 10 items of 4590 documents

Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune react…

1997

In enterobacteria-induced reactive arthritis (ReA), different T cell subsets play a role in the induction and maintenance of the synovitic process. Synovial fluid-derived alphabeta CD4, alphabeta CD8, and gammadelta T lymphocyte clones (TLC) that recognize Yersinia or Salmonella antigens on professional antigen-presenting cells (APC) have been characterized, and T cells themselves can function as nonprofessional APC. T cells were infected with the facultatively intracellular, arthritogenic enterobacterium Yersinia enterocolitica O:3. A CD8 TLC isolated from a patient with Yersinia-induced ReA recognized and efficiently lysed autologous and allogeneic Yersinia-infected T cells. Infected cyto…

Salmonella typhimuriumYersinia InfectionsT cellT-LymphocytesAntigen presentationAntigen-Presenting Cellschemical and pharmacologic phenomenaBiologyArthritis ReactiveMicrobiologyInterleukin 21MiceL CellsAntigenT-Lymphocyte SubsetsProhibitinsmedicineTumor Cells CulturedImmunology and AllergyCytotoxic T cellAnimalsHumansIL-2 receptorAntigen-presenting cellYersinia enterocoliticaAntigens BacterialB-LymphocytesImmunity CellularNatural killer T cellClone CellsMicroscopy ElectronInfectious Diseasesmedicine.anatomical_structureImmunologybacteriaT-Lymphocytes CytotoxicThe Journal of infectious diseases
researchProduct

New Acylated Triterpene Saponins from Silene fortunei that Modulate Lymphocyte Proliferation

2002

Three new acylated triterpene saponins 1-3, with a quillaic acid as aglycon, were isolated from the roots of Silene fortunei together with a known phytoecdysteroid (20-hydroxyecdysone). The compounds were characterized mainly by a combination of 2D NMR techniques, mass spectrometry, and chemical methods. Saponins 1-3, jenisseensosides C and D (4, 5), and 6 (deacylated form of 2/3 and 4/5) were found to stimulate the proliferation of the Jurkat tumor cell lines at low concentration. At high concentration, 2/3 and 4/5 inhibited the proliferation of the cells and suggested the induction of apoptosis.

SaponinPhytoecdysteroidPharmaceutical ScienceApoptosisLymphocyte proliferationPharmacognosyLymphocyte ActivationPlant RootsJurkat cellsAnalytical ChemistryJurkat CellsTriterpeneDrug DiscoveryHumansSileneNuclear Magnetic Resonance BiomolecularPharmacologychemistry.chemical_classificationSilenePlants MedicinalMolecular StructurebiologyHydrolysisOrganic ChemistryGlycosideAcetylationStereoisomerismSaponinsbiology.organism_classificationTriterpenesComplementary and alternative medicinechemistryBiochemistryMolecular MedicineJournal of Natural Products
researchProduct

Inhibition of the pro-inflammatory mediators' production and anti-inflammatory effect of the iridoid scrovalentinoside.

2007

We have studied scrovalentinoside, an iridoid with anti-inflammatory properties isolated from Scrophularia auriculata ssp. pseudoauriculata, as an anti-inflammatory agent in different experimental models of delayed-type hypersensitivity. We found that scrovalentinoside reduced the edema induced by oxazolone at 0.5 mg/ear and sheep red blood cells at 10 mg/kg. The observed effect occurred during the last phase or inflammatory response; during the earlier phase or induction of the delayed-type hypersensitivity reaction, no significant activity was noted. Thus, scrovalentinoside reduced both the edema and cell infiltration in vivo and reduced lymphocyte proliferation in vitro, affecting the cy…

ScrophulariaLeukotriene B4medicine.medical_treatmentT-LymphocytesBlotting WesternAnti-Inflammatory AgentsInflammationLymphocyte proliferationPharmacologyOxazolonechemistry.chemical_compoundMiceReceptors GlucocorticoidEdemaDrug DiscoverymedicineAnimalsEdemaHumansHypersensitivity DelayedIridoidsGlycosidesPhytohemagglutininsUnsaturated fatty acidCell ProliferationPharmacologyPlants MedicinalChemistryMacrophagesCell CycleOxazoloneRatsDisease Models AnimalCytokineEicosanoidImmunologyIridoid GlycosidesFemalePlant Preparationsmedicine.symptomInflammation MediatorsJournal of ethnopharmacology
researchProduct

Seltene Parotistumoren

2003

Tumors of the parotid gland can be benign or malignant lesions. The pathophysiology of rare tumors of the parotid gland is often not sufficiently explored. In this paper two rare histological entities are described.In one patient a benign sebaceous lymphadenoma was histologically diagnosed. This type of tumor accounts for only 0.1% of all adenomas. The international literature is not conclusive about whether the tumor originates in the parotid gland itself or in the parotid lymph nodes.The second patient presented with a metastasis from a glioblastoma in the parotid gland. Again, the mechanism for metastasis of an intracerebral tumor to the parotid gland remains unknown. Iatrogenic seeding …

Sebaceous glandPathologymedicine.medical_specialtySebaceous lymphadenomaSalivary glandbusiness.industrymedicine.diseaseParotid glandMetastasisCentral nervous system diseaseLesionstomatognathic diseasesmedicine.anatomical_structurestomatognathic systemOtorhinolaryngologymedicineHistopathologymedicine.symptombusinessHNO
researchProduct

Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study

2021

<b><i>Introduction:</i></b> In the REFLECT trial, lenvatinib was found to be noninferior compared to sorafenib in terms of overall survival. Here, we analyze the effects of lenvatinib in the real-life experience of several centers across the world and identify clinical factors that could be significantly associated with survival outcomes. <b><i>Methods:</i></b> The study population was derived from retrospectively collected data of HCC patients treated with lenvatinib. The overall cohort included western and eastern populations from 23 center in five countries. <b><i>Results:</i></b> We included 1,325 patients with HCC …

Second lineSettore MED/12 - GastroenterologiaOncologyHepatologyHepatocellular carcinomaLenvatinibNonalcoholic fatty liver diseaseTyrosine kinase inhibitors.ALBINonalcoholic steatohepatitiNeutrophils to lymphocyte ratioOutcome
researchProduct

Sepsis due to Streptococcus pneumoniae associated with secondary hemophagocytic lymphohistiocytosis in a splenectomized patient for spherocytosis

2017

Abstract Rationale: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome that is characterized by an inappropriate hyperinflammatory immune response – primary, as a consequence of a genetic defect of NK cells and cytotoxic T lymphocytes or – secondary, in the progression of infections, rheumatic or autoimmune diseases, malignancies or metabolic diseases. Patient concerns: We present the case of a secondary HLH due to Streptococcus pneumoniae infection in a splenectomised patient for spherocytosis, a 37-year-old patient who was splenectomised in childhood for spherocytosis, without immuneprophylaxis induced by antipneumococcal vaccine. Outcomes: He developed a severe pneumococcal sepsis as…

Secondary Hemophagocytic LymphohistiocytosisAdultMaleendocrine systemsplenectomized patientmedicine.medical_treatmentSpherocytosisSplenectomySpherocytosis Hereditarymedicine.disease_causeLymphohistiocytosis HemophagocyticPneumococcal InfectionsSepsis03 medical and health sciences0302 clinical medicineImmune systemFatal Outcomehemic and lymphatic diseasesSepsisStreptococcus pneumoniaemedicineCytotoxic T cellHumans030212 general & internal medicineClinical Case ReportHemophagocytic lymphohistiocytosisbusiness.industry4900General Medicinemedicine.diseaseStreptococcus pneumoniaehemophagocytic lymphohistiocytosis030220 oncology & carcinogenesisImmunologySplenectomybusinessResearch ArticleHLHMedicine
researchProduct

Secondary hemophagocytic lymphohistiocytosis: forget me not!

2012

.

Secondary Hemophagocytic LymphohistiocytosisMaleTransplantationPediatricsmedicine.medical_specialtyHemophagocytic lymphohistiocytosishemophagocytosisbusiness.industryPancytopeniamedicine.diseasePancytopeniaBrucellaTissue DonorsBrucellosisAnti-Bacterial AgentsLiver TransplantationInfectious DiseasesBrucellosimedicineHumansBrucellosis; hemophagocytosisIntensive care medicinebusiness
researchProduct

Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience

2014

Background: Optimally, secondary cytoreduction is acknowledged as a valid option in terms of oncologic outcome for patients with platinum-sensitive recurrent ovarian cancer. In cases of localized relapse, a laparoscopic approach has been attempted at various institutions, but studies on its role for this subset of patients still are limited. This report describes the authors' experience using laparoscopic secondary cytoreduction for patients with localized recurrent ovarian cancer. The results from a retrospective analysis of a prospective case series are reported. Methods: Between October 2011 and May 2013, 29 patients with localized recurrent ovarian cancer were selected for a laparoscopi…

Secondary cytoreductionmedicine.medical_treatmentTissue AdhesionsPostoperative ComplicationsLaparotomyLaparoscopyOvarian Neoplasmsmedicine.diagnostic_testMedicine (all)Middle Agedovarian cancerChemotherapy AdjuvantLymphatic MetastasisFemaleAdult; Aged; Antineoplastic Agents; Carcinoma; Chemotherapy; Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Laparoscopy; Laparotomy; Length of Stay; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Monitoring; Intraoperative; Neoplasm Recurrence; Local; Neoplasm Staging; Operative Time; Ovarian Neoplasms; Postoperative Complications; Retrospective Studies; Tissue AdhesionsAdultmedicine.medical_specialtyRecurrent ovarian cancer; Laparoscopy; Secondary cytoreductionOperative TimeAntineoplastic AgentsDisease-Free SurvivalLaparoscopicMonitoring IntraoperativeInternal medicineCarcinomamedicineHumansAgedNeoplasm StagingRetrospective StudiesLaparotomybusiness.industryGeneral surgeryCarcinomaRetrospective cohort studyLength of StayHepatologymedicine.diseaseSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIARecurrent Ovarian CancerLymph Node ExcisionSurgeryLaparoscopyNeoplasm Recurrence LocalRecurrent ovarian cancerOvarian cancerbusinessFollow-Up StudiesAbdominal surgery
researchProduct

Lack of correlation between apoptosis and DNA single-strand breaks in X-irradiated human peripheral blood mononuclear cells in the course of ageing

1998

The dependence on age of both the basal and the X-radiation-induced levels of apoptosis was examined in human peripheral blood mononuclear cells (PBMC). In the same samples, the base value and the extent of induced DNA single-strand breaks were determined, using a sensitive and fast microplate assay. PBMC were isolated from blood of donors of various age groups (20-30, 40-60 and > 70 years of age) and X-irradiated ex vivo using a 6 MV linear accelerator to give a total exposure of 4 Gy. The mean basal levels of apoptosis in PBMC from donors in the 40-60 year age group and the > 70 year age group were found to be only slightly higher (by 20-10%) compared to that of the 20-30 year age group, …

SenescenceAgingProgrammed cell deathDNA damageX-RaysDNA Single-StrandedApoptosisBiologyPeripheral blood mononuclear cellAndrologyBlood cellmedicine.anatomical_structureApoptosisAgeingImmunologyLeukocytes MononuclearmedicineHumansRadiation-induced apoptosis; T-cells; Intrinsic radiosensitivity; Ionizing-radiation; Cervical-carcinoma; Human-lymphocytes; Immune-systemEx vivoDevelopmental BiologyMechanisms of Ageing and Development
researchProduct

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.

2013

Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3). Although therapy-induced senescence (TIS) improves long-term outcomes, potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Eµ-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but …

SenescenceMaleLymphoma B-CellTransgeneApoptosisMice TransgenicMiceUbiquitinStress PhysiologicalAutophagyAnimalsCaspase 12Cellular SenescenceMultidisciplinarybiologyCaspase 3Endoplasmic reticulumAutophagyEndoplasmic Reticulum StressSurvival RateDisease Models AnimalHistoneGlucoseBiochemistryHistone methyltransferaseProteolysisUnfolded protein responsebiology.proteinCancer researchFemaleNature
researchProduct